Skip to main content

Animations

MJFF Publications

2761 - 2770 of 8404 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Different rates of cognitive decline in autosomal dominant and late‐onset Alzheimer disease
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12505
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: For Some Neurologists, COVID-19 Has Prompted an ‘Existential Crisis’
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805196.94665.be
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: How to Increase Diverse Representation in Parkinson's Disease Trials
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805216.68841.48
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson’s Disease: Focus on Neuroinflammation
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12035-021-02625-1
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    RESTRICTED
    Title: MS Study That Spans Decades Indicates Patients Benefit from Early Diagnosis and Treatment
    Journal Name: Neurology Today
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nt.0000805208.98399.94
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Multiplexed Profiling of Extracellular Vesicles for Biomarker Development
    Journal Name: Nano-Micro Letters
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s40820-021-00753-w
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000013121
    Citation Count: 86
  • Summary Details
    OPEN
    Title: The contribution of behavioral features to caregiver burden in FTLD spectrum disorders
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.12494
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: A brief history of nearly EV‐erything – The rise and rise of extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12144
    Citation Count: 176
  • Summary Details
    RESTRICTED
    Title: Amantadine in the treatment of Parkinson's disease and other movement disorders
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00249-0
    Best OA location URL:
    Citation Count: 73
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.